Rectal Carcinoma clinical trials
59 active trials name this condition. Describe your situation to see which ones you may be eligible for.
Refine by biomarker
By location
- Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer
- Randomizing Two Radiotherapy Boost Options to Avoid Rectal Cancer Surgery
- ColoSeal™ ICD System Anastomotic Protection Pivotal Study
- A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.
- Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- Trial of the Efficacy and Safety of Short and Long Course Radiation Therapy With/Without BMX-001
- NG-350A Plus Chemoradiotherapy for Locally Advanced Rectal Cancer
- Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer
- SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer
- Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
- Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer
- Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment
- Adaptive Radiation Boost for Rectal Cancer
- Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
- Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Brodalumab in the Treatment of Immune-Related Adverse Events
- Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
- Designing a Dyad-Based mHealth Intervention to Improve Adherence to Lifestyle Recommendations in Colorectal Cancer Survivors and Their Family Caregivers
- A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer
- F-Tryptophan PET/CT in Human Cancers
- Contrast-Enhanced Photon-Counting Detector CT (PCD-CT) for the Local Staging of Rectal Cancer
- Feasibility of Non-Operative Management of Rectal Cancer in a Rural Population
- Exosomes in Rectal Cancer
- Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer
- Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol
- Sample Collection for Ongoing Research and Product Evaluation Study
- A Multi Center Study of Sexual Toxicities After Radiotherapy
- The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Integrated Cancer Repository for Cancer Research
- The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer
- An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
- A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients
- Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer
- Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC)
- The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial
- Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial
- Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
- Preserving Physical Function in Older Adults With Cancer: Impact of an Optimizing Nutrition Intervention Applied Before and After Surgery
- Distance-Based Exercise to Preserve Function and Prevent Disability
- Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy
- Resilience and Equity in Aging, Cancer, and Health (REACH)
- Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer
- Improving Care for Rural Patients With Solid Tumors
- EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
- Oral 5 Strain Probiotic for GI Toxicity Mitigation During Pelvic Radiation
- Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- Combining DCSZ11 With Radiation and Chemotherapy as Neoadjuvant Treatment for pMMR Locally Advanced Rectal Cancer
- Taking a Look at Patient Experiences In Rectal Cancer Clinical Trials
- ctDNA and Organ Preservation/Pathologic CR in Rectal Cancer
- Testing Alcohol Cancer Risk Messages
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Rectal Carcinoma” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.